“We Need to Deploy Them Very Thoughtfully and Carefully”: Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States—A Qualitative Inquiry

作者: Karine Dubé , David Evans , Lynda Dee , Laurie Sylla , Jeff Taylor

DOI: 10.1089/AID.2017.0067

关键词:

摘要: Abstract Strategies to control HIV in the absence of antiretroviral therapy are needed cure HIV. However, such strategies will require analytical treatment interruptions (ATIs) determine their efficacy. We investigated how U.S. stakeholders involved research perceive ATIs. conducted 36 in-depth interviews with three groups stakeholders: 12 people living HIV, 11 clinician-researchers, and 13 policy-makers/bioethicists. Qualitative data revealed several themes. First, there was little consensus on when ATIs would be ethically warranted. Second, most frequent perceived hypothetical motivators for participating were advancing science contributing society. Third, risks related viral rebound prevalent concerns Stakeholders suggested ways minimize research. Increased cooperation between scientists local communities may useful minimizing risk. Further ethics is necessary.

参考文章(60)
Strategies for Management of Antiretroviral Therapy (SMART) Study Group, None, CD4+ count-guided interruption of antiretroviral treatment. The New England Journal of Medicine. ,vol. 355, pp. 2283- 2296 ,(2006) , 10.1056/NEJMOA062360
Liza Dawson, Sheryl Zwerski, Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention Bioethics. ,vol. 29, pp. 316- 323 ,(2015) , 10.1111/BIOE.12113
Eric S. Rosenberg, Marcus Altfeld, Samuel H. Poon, Mary N. Phillips, Barbara M. Wilkes, Robert L. Eldridge, Gregory K. Robbins, Richard T. D'Aquila, Philip J. R. Goulder, Bruce D. Walker, Immune control of HIV-1 after early treatment of acute infection Nature. ,vol. 407, pp. 523- 526 ,(2000) , 10.1038/35035103
Julianna Lisziewicz, Eric Rosenberg, Judy Lieberman, Heiko Jessen, Lucia Lopalco, Robert Siliciano, Bruce Walker, Franco Lori, Control of HIV despite the discontinuation of antiretroviral therapy. The New England Journal of Medicine. ,vol. 340, pp. 1683- 1684 ,(1999) , 10.1056/NEJM199905273402114
Laurent Hocqueloux, Thierry Prazuck, Véronique Avettand-Fenoel, Alain Lafeuillade, Bernard Cardon, Jean-Paul Viard, Christine Rouzioux, Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection AIDS. ,vol. 24, pp. 1598- 1601 ,(2010) , 10.1097/QAD.0B013E32833B61BA
R. Dresser, Aligning Regulations and Ethics in Human Research Science. ,vol. 337, pp. 527- 528 ,(2012) , 10.1126/SCIENCE.1218323
Robert F. Siliciano, Martin A. Nowak, Alison Lynn Hill, Daniel I. S. Rosenbloom, Feng Fu, Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1 Proceedings of the National Academy of Sciences of the United States of America. ,vol. 111, pp. 13475- 13480 ,(2014) , 10.1073/PNAS.1406663111
Lisa Demeter, Ronald J Bosch, Evgenia Aga, Carla Pettinelli, Martin Hirsch, Mary Vogler, Ana Martinez, Susan Little, Elizabeth Connick, Paul Volberding, Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS. ,vol. 23, pp. 1987- 1995 ,(2009) , 10.1097/QAD.0B013E32832EB285
Katherine Luzuriaga, Hannah Gay, Carrie Ziemniak, Keri B. Sanborn, Mohan Somasundaran, Kaitlin Rainwater-Lovett, John W. Mellors, Daniel Rosenbloom, Deborah Persaud, Viremic Relapse after HIV-1 Remission in a Perinatally Infected Child New England Journal of Medicine. ,vol. 372, pp. 786- 788 ,(2015) , 10.1056/NEJMC1413931
Roy Colven, Robert D Harrington, David H Spach, Calvin J Cohen, Thomas M Hooton, Retroviral Rebound Syndrome after Cessation of Suppressive Antiretroviral Therapy in Three Patients with Chronic HIV Infection Annals of Internal Medicine. ,vol. 133, pp. 430- 434 ,(2000) , 10.7326/0003-4819-133-6-200009190-00010